Sarcoma: Clinical Trials and Management
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: 29 November 2024 | Viewed by 98
Special Issue Editors
Interests: immunotherapy; melanoma; sarcoma; epigenetics; injectable intratumoral therapy
Special Issue Information
Dear Colleagues,
Sarcoma represents a heterogenous collection of mesenchymal neoplasms originating in the soft tissue and bone. There are over 50 different histologic subtypes of sarcoma, and these differ by differentiation, clinical behavior, genetics, age of occurrence, and response to different therapies. The optimal treatment of sarcoma can vary significantly between different histologic subtypes.
Over the past decade, several innovative therapies have revolutionized the field of oncology and have challenged conventional notions of cancer treatment. New molecular targets have been identified, and immunotherapy has dramatically changed the treatment landscape for multiple malignancies, including several sarcoma subtypes.
In this present Special Issue, we are particularly interested in manuscripts reporting original findings or updated literature reviews concerning the treatment of sarcoma. We seek to highlight innovative strategies that may lead to improvements in the management of bone and soft tissue sarcomas.
Prof. Dr. Mohammed M. Milhem
Dr. John Rieth
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- soft tissue sarcoma
- bone sarcoma
- chemotherapy
- immunotherapy
- targeted therapy
- radiotherapy
- pediatric sarcoma
- adult sarcoma
